For these reasons, ritanserin has been proposed for cancer treatment, for instance by Fu et al. who exploited its capability to highlight the DGKα role in non‐small cell lung cancer‐related metastasis in vitro and in vivo [34]. The gene discussed is DGKA; the disease is cancer.